"Clayton Sleep Institute is comprised of Board Certified sleep specialists and scientists, Registered Sleep Technologists and Registered Respiratory Therapists with years of experience in the field of sleep disorders. CSI is an independent sleep laboratory accredited by the American Academy of Sleep Medicine. We treat the full range of sleep disorders for patients of all ages. We participate in and lead clinical research into the science and medicine of sleep. We develop, sponsor and produce sleep education programs for patients, medical professionals, scientists and the general public. Learn how Clayton Sleep Institute can help you have better sleep and a better life. Make an appointment today."

During the past decade, Clayton Sleep Institute conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 17 clinical trials were completed, i.e. on average, 54.8% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 15 clinical trials were completed. i.e. 78.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clayton Sleep Institute" #1 sponsor was "Philips Respironics" with 6 trials, followed by "Fisher and Paykel Healthcare" with 5 trials sponsored, "Jazz Pharmaceuticals" with 5 trials sponsored, "Apnimed" with 2 trials sponsored and "Clayton Sleep Insititute" with 2 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clayton Sleep Institute" #1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator, "Clayton Sleep Insititute" with 1 trials as a collaborator, "Cooperative Research Center (CRC) for Alertness, Safety and Productivity" with 1 trials as a collaborator, "HealthCore-NERI" with 1 trials as a collaborator and "Mayo Clinic" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Clayton Sleep Institute" are "Obstructive Sleep Apnea" (12 trials), "Sleep Apnea, Obstructive" (5 trials), "Idiopathic Hypersomnia" (4 trials), "Narcolepsy" (4 trials) and "Restless Legs Syndrome" (2 trials). Many other conditions were trialed in "Clayton Sleep Institute" in a lesser frequency.

Most popular intervention types in "Clayton Sleep Institute" are "Drug" (19 trials), "Device" (18 trials), "Other" (3 trials), "Diagnostic Test" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "JZP-110" (3 trials), "Placebo" (3 trials), "Placebo oral tablet" (3 trials), "JZP-258" (2 trials) and "eXciteOSA" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clayton Sleep Institute" are 42 trials for "All" genders.

Currently, there are 8 active trials in "Clayton Sleep Institute". 1 are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 33 completed trials in Clayton Sleep Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Clayton Sleep Institute, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 16 trials that are defined as “Not Applicable".